1 ith skin or is ingested, it causes a painful burning sensation.

2  in foreign body sensation, and reduction in burning sensation.

3 ng pain is followed by a C-related prolonged burning sensation.

4        Other symptoms were dryness, redness, burning sensation and itching.

5    It is activated by compounds that cause a burning sensation (e.g., mustard oil) and, indirectly, b

6 atients; headache, nine (3.3%) patients; and burning sensation, eight (2.9%) patients.

7 ion, such as pain, discomfort, tingling, and burning sensations, have rarely been reported in Parkins

8 t correlation between difficulty swallowing, burning sensation in the mouth, vomiting, acidic taste,

9 ress as shown by the associations with pain, burning sensation, nausea, and bloating scores.

10 ized by redness of the skin and intermittent burning sensation of extremities, is not known, two muta

11 getfulness); headache; and skin lesions or a burning sensation of skin on contact with water.

12 n (P-treatment x time interaction < 0.0005), burning sensation (P-treatment x time interaction < 0.00

13 g (P <0.001), dry mouth (P <0.001), and oral burning sensations (P <0.05) were worse among patients i

14  are spatially interlaced produces a painful burning sensation resembling that caused by intense, nox

15 eover, both groups decreased the presence of burning sensation, tearing, foreign body sensation, conj

16  later experienced occasional body weakness, burning sensation, tingling and numbness of the feet, fa

17            All patients complained of a mild burning sensation upon application of the ointment.

18                                     However, burning sensation was more pronounced with tacrolimus (P

19                     Skin redness and heat or burning sensations were more frequent in the double acti

20 rostomia with TCAs; and peripheral edema and burning sensation with pregabalin and capsaicin.